BioLine RX Ltd
BLRX3.730USD
-0.090-2.36%
終値 10/17, 16:00（ET）15分遅れの株価
9.54B時価総額
損失額直近12ヶ月PER
詳細情報 BioLine RX Ltd 企業名
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BioLine RX Ltdの企業情報
企業コードBLRX
会社名BioLine RX Ltd
上場日Jan 30, 2007
最高経営責任者「CEO」Mr. Philip Adam (Phil) Serlin
従業員数28
証券種類Ordinary Share
決算期末Jan 30
本社所在地Modi'in Technology Park
都市MODIIN
証券取引所Tel Aviv Stock Exchange
国Israel
郵便番号7177871
電話番号97286429100
ウェブサイトhttps://www.biolinerx.com/
企業コードBLRX
上場日Jan 30, 2007
最高経営責任者「CEO」Mr. Philip Adam (Phil) Serlin
BioLine RX Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
Dr. Barbara-Jean (BJ) Bormann
Dr. Barbara-Jean (BJ) Bormann
Director
Director
--
--
Mr. Gal Cohen
Mr. Gal Cohen
Independent Director
Independent Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Ms. Mali Zeevi
Ms. Mali Zeevi
Chief Financial Officer
Chief Financial Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Hong Seng Technology Ltd
3.92%
Citadel Advisors LLC
0.34%
Simplex Trading, LLC
0.32%
Two Sigma Investments, LP
0.32%
Susquehanna International Group, LLP
0.26%
他の
94.84%
株主統計
株主統計
比率
Hong Seng Technology Ltd
3.92%
Citadel Advisors LLC
0.34%
Simplex Trading, LLC
0.32%
Two Sigma Investments, LP
0.32%
Susquehanna International Group, LLP
0.26%
他の
94.84%
種類
株主統計
比率
Corporation
4.00%
Hedge Fund
0.66%
Research Firm
0.47%
Investment Advisor
0.38%
他の
94.49%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
62
66.21K
1.52%
-51.16K
2025Q2
62
197.43K
4.63%
-93.51K
2025Q1
65
183.31K
4.30%
-165.57K
2024Q4
63
222.04K
6.08%
+67.69K
2024Q3
62
233.17K
7.79%
-25.85K
2024Q2
66
277.79K
10.04%
+89.80K
2024Q1
64
205.72K
6.62%
+27.03K
2023Q4
67
200.88K
6.35%
-8.70K
2023Q3
69
34.99K
2.17%
-169.90K
2023Q2
63
31.93K
2.08%
-207.57K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Hong Seng Technology Ltd
170.73K
3.92%
--
--
Mar 16, 2025
Citadel Advisors LLC
14.95K
0.34%
+14.95K
--
Jun 30, 2025
Simplex Trading, LLC
14.11K
0.32%
+14.11K
--
Jun 30, 2025
Two Sigma Investments, LP
13.82K
0.32%
+13.82K
--
Jun 30, 2025
Susquehanna International Group, LLP
11.10K
0.26%
+11.10K
--
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
4.28K
0.1%
+2.75K
+179.41%
Jun 30, 2025
Citi Investment Research (US)
4.00K
0.09%
+4.00K
--
Jun 30, 2025
Intracoastal Capital, L.L.C.
3.13K
0.07%
+3.13K
--
Mar 16, 2025
Wells Fargo Advisors
1.75K
0.04%
-1.25K
-41.67%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
900.00
0.02%
--
--
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Mon, Oct 6
更新時刻: Mon, Oct 6
銘柄名
比率
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jan 17, 2025
Merger
40→1
Jan 17, 2025
Merger
40→1
Jan 17, 2025
Merger
40→1
Jan 17, 2025
Merger
40→1
日付
種類
比率
Jan 17, 2025
Merger
40→1
Jan 17, 2025
Merger
40→1
Jan 17, 2025
Merger
40→1
Jan 17, 2025
Merger
40→1
